Brief: BioMerieux Receives IVDR Class D CE Marking For 2 Syndromic Tests Including MERS-CoV
BRIEF-BioMerieux Receives IVDR Class D CE Marking For 2 Syndromic Tests Including MERS-CoV Sept 16 (Reuters) - Biomerieux SA BIOX.PA:
RECEIVES IVDR CLASS D CE MARKING FOR BIOFIRE RESPIRATORY 2.1 PLUS PANEL AND BIOFIRE FILMARRAY PNEUMONIA PLUS PANEL
THE NEWLY IVDR CERTIFIED PANELS WILL BEGIN TO BE AVAILABLE ON THE EUROPEAN MARKET EARLY NEXT YEAR
NEWLY IVDR CERTIFIED PANELS WILL BEGIN TO BE AVAILABLE ON THE EUROPEAN MARKET EARLY NEXT YEAR
CLASSIFICATION IS DRIVEN BY INCLUSION OF MERS-COV ON BOTH TEST MENUS
Source text: https://tinyurl.com/44yv2tn7
Further company coverage: BIOX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Biomerieux SA
See all newsBrief: Biomerieux Receives US FDA 510(K) Clearance And Ivdr CE Marking For Vitek Pro
Brief: bioMerieux Receives FDA Clearance For Latest Versions Of Biofire® Filmarray
Europe Research Roundup: Asos, Erste Group, SCHOTT pharma
Europe Research Roundup: Acceler8 Ventures, Hermes, Soitec
BioMerieux shares rise after Q3 sales beat